Fargo, N.D. – The North Dakota Department of Agriculture awarded a $1.1 million Bioscience Innovation grant to Imricor Medical Systems, a Minnesota‑based medical‑device company, even though the firm’s plan to open a manufacturing facility in Fargo fell through.
Audit finds many grants went to ineligible recipients
A state audit released this week shows that nearly half of the $8.4 million in grants distributed to 39 companies were given to recipients that did not meet the program’s eligibility requirements. The audit does not name the companies, but it confirms that Imricor received the largest single award.
Imricor’s original proposal
According to a 2023 press release from the Department of Agriculture, Imricor was awarded $1,158,000 to complete the final steps of commercializing a new cardiac‑ablation technology. The company, headquartered in Burnsville, Minnesota, claimed it would create 20 high‑paying technical jobs by repurposing a 15,000‑square‑foot office in the Fargo‑Moorhead metro area.
“Their total proposal was for $8.8 million,” Agriculture Commissioner Doug Goehring told The Forum. “They did receive $1.1 million.”
Facility never opened
Goehring said Imricor’s plans to move to Fargo “fell through,” but the company continued to develop its products remotely. “They weren’t able to move, but they continued to do the work, and they did develop the products they said they would,” he added.
State Auditor Josh Gallion disagreed with the commissioner’s interpretation of the grant’s purpose. “When you talk about operating, and when you look at the purpose of this grant, it seems like this is to help foster and create a bioscience industry in North Dakota, which would, to me, imply that these businesses should be here creating jobs for North Dakotans,” Gallion said.
Oversight gaps highlighted
The audit also found the Agriculture Department did not conduct site visits or performance reviews for many grant recipients, and it relied heavily on the Bioscience Association of North Dakota to verify eligibility. Goehring argued that the law gave his office limited authority to oversee the program, calling the legislation “poorly written” and in need of a complete overhaul.
“I believe in the program,” Goehring said. “Bioscience is awesome. It’s a great program. We did a lot of fantastic work that the public benefited from, the world has benefited from. That being said, I had very little authority to require or do certain things.”
Other funding and the company’s status
Imricor also received a $1 million loan from the North Dakota Development Fund in 2023, which the company declined, and a $1.5 million loan from the Innovation Technology Loan Fund (LIFT), which it has since repaid in full. The firm did not receive any local tax incentives.
In November 2025, Imricor withdrew its registration as a North Dakota business, and the Secretary of State now lists the company as inactive in the state.
Local reaction
Economic development officials had initially promoted the project as a boost to the regional bioscience sector, citing partnerships with North Dakota State University and the Greater Fargo‑Moorhead Economic Development Corp. However, NDSU spokeswoman Jennifer Burris said the university has not heard from Imricor since early 2023.
Critics argue that keeping the grant despite the failed facility undermines public confidence in state‑funded innovation programs. Supporters, including Commissioner Goehring, contend that Imricor fulfilled its research and development commitments and therefore deserves the funding.
What’s next?
State lawmakers and the Agriculture Department are expected to review the grant program’s statutes to tighten eligibility criteria and improve oversight. The audit’s findings may prompt legislative action to ensure future bioscience grants directly create jobs for North Dakotans.
Original reporting: InForum (Fargo section) — read the source article.